DETECTION OF ANTIPLATELET ANTIBODY WITH A PLATELET IMMUNOFLUORESCENCE ASSAY

被引:41
作者
KRISTENSEN, AT [1 ]
WEISS, DJ [1 ]
KLAUSNER, JS [1 ]
LABER, J [1 ]
CHRISTIE, DJ [1 ]
机构
[1] UNIV MINNESOTA,COLL VET MED,DEPT SMALL ANIM CLIN SCI,MINNEAPOLIS,MN 55455
关键词
D O I
10.1111/j.1939-1676.1994.tb03193.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
An indirect platelet immunofluorescence assay (PIFA) was developed for detection of circulating antiplatelet antibody in dogs with suspected immune‐mediated thrombocytopenia (ITP). The PIFA was performed on 10 healthy dogs with normal platelet counts; 76 thrombocytopenic dogs, 20 of which were suspected of having ITP; and 18 dogs with other diseases and normal platelet counts. All normal dogs had negative test results. Fourteen (70%) of 20 dogs suspected of having ITP had positive test results. Fifteen of the remaining 56 thrombocytopenic dogs had positive test results, 9 had cancer and 6 had other immune‐mediated diseases including systemic lupus erythematosus (SLE). In this study, the PIFA assay seemed to be more sensitive (70%) than the megakaryocyte immunofluorescence assay (41 %) in the diagnosis of ITP. Of the 9 PIFA‐positive dogs with neoplasia, 6 had lymphoproliferative disorders. The PI FA was positive in 5 of 18 diseased dogs with normal platelet counts. There was an inverse relationship between the platelet count and the intensity of fluorescence in the PIFA‐positive dogs. We conclude that the PIFA is a sensitive screening method for detecting circulating antiplatelet antibody. © 1994 American College of Veterinary Internal Medicine
引用
收藏
页码:36 / 39
页数:4
相关论文
共 23 条
[1]  
Thomason KJ, Feldman BF., Immune‐mediated thrombocytopenia: diagnosis and treatment, Comp Contin Educ, 7, pp. 569-576, (1985)
[2]  
Williams DA, Maggio-Price L., Canine immune‐mediated thrombocytopenia: clinical observations and long‐term follow‐up in 54 cases, J Am Vet Med Assoc, 185, pp. 660-662, (1984)
[3]  
Jackson ML, Kruth SA., Immune‐mediated hemolytic anemia and thrombocytopenia in the dog: a retrospective study of 55 cases, Can Vet J, 26, pp. 245-250, (1985)
[4]  
Wilkins RJ, Hurvitz AI, Dodds-Laffin JW., Immunologically mediated thrombocytopenia in the dog, J Am Vet Med Assoc, 163, pp. 277-282, (1973)
[5]  
Helfand SC, Couto CG, Madewell BR., Immune‐mediated thrombocytopenia associated with solid tumors in dogs, J Am Anim Hosp Assoc, 21, pp. 787-793, (1985)
[6]  
Karpatkin S., Autoimmune thrombocytopenic purpura, Semin Hematol, 22, pp. 260-288, (1985)
[7]  
Joshi BC, Jain NC., Experimental immunologic thrombocytopenia in dogs: a study of thrombocytopenia and megakaryocytopoiesis, Res Vet Sci, 22, pp. 11-17, (1977)
[8]  
Kernoff LM, Blake CH, Shackleton D., Influence of the amount of platelet‐bound IgG on platelet survival and site of sequestration in autoimmune thrombocytopenia, Blood, 5, pp. 730-733, (1980)
[9]  
Davenport DJ, Breitschwerdt EB, Carakostas MC, Et al., Platelet disorders in the dog and cat. Part II: diagnosis and management, Comp Contin Educ, 4, pp. 788-794, (1982)
[10]  
Joshi BC, Jain NC., Detection of antiplatelet antibody in serum and on megakaryocytes of dogs with autoimmune thrombocytopenia, Am J Vet Res, 37, 6, pp. 681-685, (1976)